ClinicalTrials.gg
RecruitingNCT07888478SURGUTUpdated Oct 22, 2026

Surgical Intuition in Anastomotic Leakage After Colorectal Surgery

An observational study in Anastomotic Leaks, sponsored by University Hospital, Basel, Switzerland. Recruiting at 2 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by University Hospital, Basel, Switzerland · Observational

Updated Oct 22, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
4,300
Ages
18 Years and older
Sex
All
01

Study summary

The SURGUT study aims to assess how well a computer model predicts bowel leaks after surgery. It will also examine whether adding surgeons' intuition improves these predictions.

The study will include adults having surgery to remove part of the colon or rectum. During the operation, the remaining bowel ends are joined together. Sometimes, this connection does not heal properly and a leak develops. This is called an anastomotic leak and can cause serious complications.

The research questions are:

  • How well does a previously developed computer model predict a leak within 30 days after surgery?
  • How accurately do surgeons estimate the risk of a leak?
  • Does combining the computer model with surgeons' assessments improve prediction compared with the model alone?

This observational study will take place at several hospitals in different countries. Researchers will collect information about participants' health, surgery, and presence of complications. Surgeons will complete a pre-operative and an immediately post-operative questionnaire about the estimated risk of a leak, surgical difficulty, and concerns about the bowel connection.

Researchers will record whether a leak occurs within 30 days after surgery. They will compare these outcomes with the predictions from the computer model, surgeons' assessments, and the combination of both.

The findings may help improve how clinicians identify people at higher risk of a leak after bowel surgery.

Read the detailed description

Background : Anastomotic leakage (AL) is a disruption of bowel-wall integrity at the anastomosis that creates communication between the intestinal lumen and the extraluminal space. A pelvic abscess adjacent to the anastomosis is also considered AL. AL is a major complication after colorectal surgery. Despite established risk factors and existing prediction models, reliable prediction in individual patients remains challenging.

Rationale: SURGUT aims to prospectively validate the machine learning model developed by Ochs, Taha-Mehlitz, and colleagues and determine whether adding structured assessments of surgical intuition improves prediction. Surgeons' preoperative and immediately post-operative judgments may capture clinically relevant information not represented by the model's variables.

Methods: This prospective, international, multicenter observational cohort study will enroll adults undergoing colorectal resection with an anastomosis in two cohorts: colon and rectal resections. Clinical and operative data, surgeons' assessments recorded before and immediately after surgery, and 30-day postoperative outcomes will be collected using REDCap. All anastomotic leaks diagnosed within 30 days will be included, regardless of severity (ISREC grades A-C). The study will not alter standard clinical care.

The primary outcome is model discrimination for AL within 30 days, measured by the area under the receiver operating characteristic curve (AUC) with a 95% confidence interval. Secondary outcomes are AL incidence, discrimination of surgeons' risk estimates, and the additional predictive value of surgical intuition, assessed using ΔAUC and net reclassification improvement. Analyses will include paired AUC comparisons and multivariable logistic regression.

02

Conditions studied

  • Anastomotic Leaks

Keywords

  • Colorectal surgery
  • Anastomotic leakage
  • Machine learning
  • Risk prediction
  • Surgical intuition
  • Clinical judgment
  • Prospective validation
  • Postoperative complications
03

In context

Anastomotic Leak

218 studies on the registry are indexed under Anastomotic Leak; 62 are open to participants now.

This study's planned enrollment of 4,300 is above the median of 194 across 114 observational studies indexed under Anastomotic Leak.

Browse Anastomotic Leak studies →

Lead sponsor

University Hospital, Basel, Switzerland is the lead sponsor of 989 studies on the registry; 191 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients undergoing colorectal surgery with creation of an anastomosis at participating international surgical centers during the recruitment period. The study population includes patients undergoing surgery for malignant and nonmalignant colorectal conditions. Participants will be grouped into colon resection and rectal resection cohorts according to the procedure performed.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Undergoing colorectal surgery with creation of an anastomosis.
  • Indication for surgery: malignancy or suspected malignancy, diverticulitis, ischemia, perforation, bleeding, volvulus, stenosis or obstruction, iatrogenic injury, or inflammatory bowel disease.
  • Availability of general informed consent.

Exclusion criteria

Exclusion Criteria:

  • Age younger than 18 years.
  • Refusal to participate in the study.
  • Incomplete datasets
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
4,300 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Groups and cohorts

  • Colon resection

    Participants undergoing colon resection with primary anastomosis. Clinical and operative data, structured assessments of surgical intuition, and the occurrence of anastomotic leakage within 30 days after surgery will be recorded prospectively. Analyses will evaluate the predictive performance of the previously developed machine learning model and the additional predictive value of surgical intuition in this cohort.

  • Rectal resection

    Participants undergoing rectal resection with primary anastomosis. Clinical and operative data, structured assessments of surgical intuition, and the occurrence of anastomotic leakage within 30 days after surgery will be recorded prospectively. Analyses will evaluate the predictive performance of the previously developed machine learning model and the additional predictive value of surgical intuition in this cohort.

06

What researchers measure

Primary outcomes

  1. Discriminative performance of the machine learning model for predicting anastomotic leakage

    Area under the receiver operating characteristic curve (AUC), with a 95% confidence interval, for the previously developed machine learning model in predicting anastomotic leakage within 30 days after surgery. Model-predicted risks will be compared with observed leakage outcomes in the colon and rectal resection cohorts. Higher AUC values indicate better discrimination.

    Time frame: Within 30 days after surgery

Secondary outcomes

  1. Incidence of anastomotic leakage

    Percentage of participants who develop anastomotic leakage within 30 days after surgery, reported for the colon and rectal resection cohort

    Time frame: Within 30 days after surgery

  2. Predictive accuracy of surgical intuition for anastomotic leakage

    Predictive performance of surgeons' estimated probabilities of anastomotic leakage, recorded using structured preoperative and postoperative questionnaires. Discrimination will be assessed using the area under the curve (AUC), comparing surgeons' risk estimates with observed leakage outcomes within 30 days after surgery.

    Time frame: Preoperative assessment on day -1 or day 0 and post-operative assessment on day 0, with outcome follow-up through postoperative day 30

  3. Difference in AUC after adding surgical intuition to the machine learning model

    Difference in the area under the receiver operating characteristic curve (Delta AUC) between the model incorporating surgical intuition and the original machine learning model alone for predicting anastomotic leakage within 30 days. Paired AUC comparisons will assess the additional discriminative value of surgical intuition. Positive differences indicate improved discrimination.

    Time frame: Within 30 days after surgery

  4. Net reclassification improvement after adding surgical intuition to the machine learning model

    Net reclassification improvement (NRI) comparing the model incorporating surgical intuition with the original machine learning model alone. This measure will evaluate changes in predicted risk for participants with and without anastomotic leakage within 30 days after surgery.

    Time frame: Within 30 days after surgery

07

Study locations

2 of 2 sites recruiting
  • Kantonsspital Baselland (KSBL)
    Liestal, Basel-Landschaft 4410, Switzerland
    • Anas Taha, MD · Contact
    Recruiting
  • Clarunis Universitäres Bauchzentrum Basel
    Basel, Canton of Basel-City 4002, Switzerland
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2028, 26 months after the start.

Of 52 non-industry observational studies under Anastomotic Leak, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 98. This study's planned 26 months is below that.

Counting every sponsor, half of 54 studies reached it within 36 months; a quarter within 22 and three quarters within 98.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 22, 2026
StartActual
Oct 1, 2026
Primary completionEst.
Dec 31, 2028
CompletionEst.
Jan 31, 2029
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07888478
Collaborators
Universitätsklinikum Hamburg-Eppendorf, University Hospital Muenster, Wuerzburg University Hospital, Klinikum Chemnitz gGmbH, University Hospital of Heraklion, Military University Hospital, Prague, East Carolina University Brody School of Medicine, Goethe University, Annunziata Hospital, Cosenza, Italy, Dalhousie University
Responsible party
Sponsor
First posted
Oct 22, 2026
Start date
Oct 1, 2026
Primary completion
Dec 31, 2028 (estimated)
Completion
Jan 31, 2029 (estimated)
Last update
Oct 22, 2026

Study contacts

Stephanie G Taha-Mehlitz, MD
Contact
stephanie.taha@usb.ch
+4161 777 73 09
Helene L Gros, MD
Contact
helenelucie.gros@usb.ch
+41617777333
Stephanie G Taha-Mehlitz, MD
principal investigator · Universitätsspital Basel - Bauchzentrum

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion